ZA856547B - Controlled-release medical preparations - Google Patents

Controlled-release medical preparations

Info

Publication number
ZA856547B
ZA856547B ZA856547A ZA856547A ZA856547B ZA 856547 B ZA856547 B ZA 856547B ZA 856547 A ZA856547 A ZA 856547A ZA 856547 A ZA856547 A ZA 856547A ZA 856547 B ZA856547 B ZA 856547B
Authority
ZA
South Africa
Prior art keywords
drug
controlled
tablet
active substance
medical preparations
Prior art date
Application number
ZA856547A
Other languages
English (en)
Inventor
Ake Richard Lindahl
Bo Magnus Ekman
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of ZA856547B publication Critical patent/ZA856547B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA856547A 1984-09-06 1985-08-28 Controlled-release medical preparations ZA856547B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (1)

Publication Number Publication Date
ZA856547B true ZA856547B (en) 1986-04-30

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856547A ZA856547B (en) 1984-09-06 1985-08-28 Controlled-release medical preparations

Country Status (21)

Country Link
US (1) US4824678A (de)
EP (1) EP0173928B1 (de)
JP (1) JP2527713B2 (de)
KR (1) KR930003114B1 (de)
AT (1) ATE53490T1 (de)
AU (1) AU576891B2 (de)
CA (1) CA1252723A (de)
DE (1) DE3578123D1 (de)
DK (1) DK164256C (de)
ES (1) ES8702138A1 (de)
FI (1) FI87042C (de)
GR (1) GR852158B (de)
HU (1) HU194495B (de)
IE (1) IE58263B1 (de)
IL (2) IL76257A (de)
NO (1) NO169996C (de)
NZ (1) NZ213245A (de)
PH (1) PH22119A (de)
PT (1) PT81092B (de)
SE (1) SE8404467D0 (de)
ZA (1) ZA856547B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
WO1985003436A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
ES2215207T3 (es) * 1993-03-09 2004-10-01 Baxter International Inc. Microparticulas de macromoleculas y metodos de produccion.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (de) * 1998-12-04 2000-06-07 Synthelabo Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
SK9132003A3 (en) * 2001-12-19 2004-02-03 Astrazeneca Ab A film coating composition, a coating film, pharmaceutical formulation comprising same and a process for its production
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル, インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
TR201801650T1 (tr) 2015-08-07 2018-03-21 Santa Farma Ilac Sanayii Anonim Sirketi Kontrollü salim propi̇veri̇n formülasyonlari
WO2020101586A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations
EP4251154A4 (de) 2020-11-27 2024-07-31 Santa Farma Ilac Sanayii A.S. Propiverin enthaltende formulierungszusammensetzungen mit verzögerter freisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (de) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (de) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmazeutische Zusammensetzung in fester Verabreichungsform und Verfahren zu ihrer Herstellung
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
DK400685D0 (da) 1985-09-02
FI87042C (fi) 1992-11-25
FI853406A0 (fi) 1985-09-05
AU576891B2 (en) 1988-09-08
IE852070L (en) 1986-03-06
ATE53490T1 (de) 1990-06-15
IL76257A (en) 1989-05-15
NO169996C (no) 1992-09-02
ES8702138A1 (es) 1986-12-16
PT81092B (pt) 1988-01-22
NO853407L (no) 1986-03-07
DK164256C (da) 1992-10-19
EP0173928A1 (de) 1986-03-12
SE8404467D0 (sv) 1984-09-06
EP0173928B1 (de) 1990-06-13
KR860002271A (ko) 1986-04-24
ES546728A0 (es) 1986-12-16
NZ213245A (en) 1988-06-30
KR930003114B1 (ko) 1993-04-19
FI87042B (fi) 1992-08-14
FI853406L (fi) 1986-03-07
AU4693585A (en) 1986-03-13
DK400685A (da) 1986-03-07
GR852158B (de) 1986-01-08
IL76256A0 (en) 1986-01-31
PT81092A (en) 1985-10-01
DK164256B (da) 1992-06-01
JPS61112013A (ja) 1986-05-30
HU194495B (en) 1988-02-29
IL76256A (en) 1990-06-10
IE58263B1 (en) 1993-08-25
NO169996B (no) 1992-05-25
PH22119A (en) 1988-06-01
HUT40333A (en) 1986-12-28
DE3578123D1 (de) 1990-07-19
US4824678A (en) 1989-04-25
JP2527713B2 (ja) 1996-08-28
CA1252723A (en) 1989-04-18

Similar Documents

Publication Publication Date Title
PT81092A (en) Controlled-release medical preparations
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
IE883810L (en) Sustained release pharmaceutical compositions
CA2033277A1 (en) Controlled release pharmaceutical preparation and method for producing the same
DE3855852D1 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
EP0213083A3 (de) Tablette mit gesteuerter Wirkstoffabgabe
CA2281420A1 (en) Preparation of pharmaceutically-active granules
CA2281473A1 (en) Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
EP0171528A3 (de) Pharmazeutische Präparate mit verzögerter Abgabe
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
MY100081A (en) Sustained release theophylline.
CA2417887A1 (en) Particulate composition of eletriptan
AUPM814994A0 (en) Codeine-containing formulations
JPS5549312A (en) Preparation of slow-releasing medicine
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.